Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
7 studies found for:    "Cutaneous mastocytosis"
Show Display Options
Rank Status Study
1 Completed Efficacy and Safety of TF002 in Cutaneous Mastocytosis
Condition: Cutaneous Mastocytosis
Intervention: Drug: TF 002
2 Unknown  A Phase 3 Study to Compare Efficacy and Safety of Masitinib to Placebo in the Treatment of Patients With Smouldering Systemic, Indolent Systemic or Cutaneous Mastocytosis With Handicap
Conditions: Smouldering Systemic Mastocytosis;   Indolent Systemic Mastocytosis;   Cutaneous Mastocytosis With Handicap;   Mastocytosis
Interventions: Drug: masitinib (AB1010);   Drug: placebo
3 Not yet recruiting Cutaneous Mastocytosis in Children: Analysis of Somatic and Germline Mutations
Conditions: Urticaria Pigmentosa;   Cutaneous Mastocytosis
Interventions: Other: skin biopsy;   Other: blood draw
4 Recruiting Mast Cell Connect: A Registry for Patients With Mastocytosis
Condition: Mastocytosis
5 Terminated Evaluation of Patient Satisfaction With and Acceptance of Their Totally-implanted Central Venous Catheter
Conditions: Malignant Mast Cell Tumors;   Solid Organ Sites
6 Recruiting Diagnostic Value of Bone Marrow Tryptase in Systemic Mastocytosis
Condition: Systemic Mastocytosis
Intervention: Procedure: Mastocytosis diagnosis
7 Completed Natural History of Urticaria Pigmentosa in Children
Condition: Urticaria Pigmentosa

Indicates status has not been verified in more than two years